Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONOPOLY dupilumab response biomarker study in adult CRSwNP
NL-OMON24913Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Amsterdam University Medical Center. Started Jan 2021; status: recruiting.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NL-OMON24913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24913.